Summary
- Current Price
- As of today, HELP price is $6.09, up +2.87% on
- Current Price All-Time High
- HELP price is currently -95.26% below its historical high of $128.44 set on
- Market Cap
- HELP current market cap is $304M, up +52.60% over the past 365 days
- PE Ratio
- HELP PE ratio is unknown
- Revenue
- HELP current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for HELP is on
Profile
| Metric | Value |
|---|---|
| Full Name | Cybin D/B/A Helus Pharma |
| Ticker | NASDAQ: HELP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Canada |
| IPO | |
| Indexes | Not included |
| Website | cybin.com |
| Employees | 50 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $6.09 | ||
| Price, 1D Change | +2.87% | |
| $304M | ||
| - | ||
| - | ||
| 1.04 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$4.02 | ||
| EPS, 1Y Change | -38.96% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | CYBN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$4.02 | ||
| EPS Estimate | -$4.81 | |
| EPS Est. Change | -19.64% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| $6.09 | ||
| Price Target | - | $48.43 |
| Price Tgt. Change | - | +695.17% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.81 | N/A | - | |
| -$4.03 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -35.69% | ||
| -60.72% | ||
| +52.60% | ||
| +291.99% | ||
| 0.00% | ||
| 0.00% | ||
| -38.96% | ||
| +67.17% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $6.09 | ||
| $6.99 | ||
| SMA 200 vs Price | +14.80% | |
| $7.04 | ||
| SMA 50 vs Price | +15.67% | |
| 1.04 | ||
| $0.54 | ||
| 38.91 | ||
| 79.46% | ||
| 72.25% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$4.02 | ||
| -$341.50K | ||
| - | ||
| -$102.91M | ||
| - | ||
| -$81.34M | ||
| - | ||
| -$102.57M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 7.75 | ||
| 7.75 | ||
| - | ||
| - | ||
| 9.19 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 2.19 | ||
| -2.52 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $164.81M | ||
| $93.81M | ||
| $179.69M | ||
| $115.32M | ||
| $14.88M | ||
| $14.88M | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 |
Expenses
| Metric | Date | Value |
|---|---|---|
| $81.34M | ||
| $102.57M | ||
| $341.50K | ||
| $32.62M | ||
| $341.50K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$72.83M | ||
| -$1.41M | ||
| $14.52M | ||
| $1.41M | ||
| -$74.24M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Guggenheim | → | |
| Canaccord Genuity | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with HELP
FAQ
What is the ticker symbol for Cybin D/B/A Helus Pharma?
The ticker symbol for Cybin D/B/A Helus Pharma is NASDAQ:HELP
Does Cybin D/B/A Helus Pharma pay dividends?
No, Cybin D/B/A Helus Pharma does not pay dividends
What sector is Cybin D/B/A Helus Pharma in?
Cybin D/B/A Helus Pharma is in the Healthcare sector
What industry is Cybin D/B/A Helus Pharma in?
Cybin D/B/A Helus Pharma is in the Biotechnology industry
What country is Cybin D/B/A Helus Pharma based in?
Cybin D/B/A Helus Pharma is headquartered in Canada
When did Cybin D/B/A Helus Pharma go public?
Cybin D/B/A Helus Pharma initial public offering (IPO) was on September 13, 2019
Is Cybin D/B/A Helus Pharma in the S&P 500?
No, Cybin D/B/A Helus Pharma is not included in the S&P 500 index
Is Cybin D/B/A Helus Pharma in the NASDAQ 100?
No, Cybin D/B/A Helus Pharma is not included in the NASDAQ 100 index
Is Cybin D/B/A Helus Pharma in the Dow Jones?
No, Cybin D/B/A Helus Pharma is not included in the Dow Jones index
When was Cybin D/B/A Helus Pharma last earnings report?
Cybin D/B/A Helus Pharma's most recent earnings report was on February 13, 2026
When does Cybin D/B/A Helus Pharma report earnings?
The next expected earnings date for Cybin D/B/A Helus Pharma is July 1, 2026
Data Sources & References
- HELP Official Website cybin.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1833141/000106299325016352/0001062993-25-016352-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1833141/000162828025033606/0001628280-25-033606-index.htm
- HELP Profile on Yahoo Finance finance.yahoo.com/quote/HELP
- HELP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/help